← All peptides
warningBioGate · AMBERGrade B

Ipamorelin

AHwFK

Pentapeptide ghrelin-receptor agonist; selectively stimulates GH release without significant cortisol or prolactin elevation.

NH₂ terminusselective GHS-R agonist
MW
711.86
Length
5aa
Posterior
67.6%
Structural preview · ESMFold-2 mockdeterministic per sequence
Backbone preview · NH₂ terminus
PDA-V1 attestation

Cryptographic chain of custody.

Outer PDA hash
Inputs hash
Merkle root
TEE attestation
Protocol version
PDA-V1
Source
peptide-md
Model version
structure-fm-2026.04
Candidates emitted
2
Signed
2026-04-21T08:14:33Z
Verifiable in your browser at /verifier with @peptide-md/verifier.
Verify this attestation →Download dossier (PDF)Compare with…
Real-world evidence

Cohort-attested outcomes.

Cohorts
5
Participants
295
Mean Δ
-1.26
Δ HRV ms (8-week) · 95% CI [-1.85, -0.66]
IPNFT - Not minted

This peptide is not currently represented as an IPNFT. Cohort outcomes feed back into the unminted pool.

Used in protocols

Where this peptide shows up.

Lean Mass & Recovery Stack

Grade B

Off-label growth-hormone optimization for adults with confirmed somatopause profile

Citations

Source literature.

Grade B1998 · Eur J Endocrinol

Ipamorelin, the first selective growth hormone secretagogue

Raun K et al.

PMID 9920077